MedTrace Logo

Effects Of Post Isometric Relaxation And Post Facilitation Stretching On ROM, Pain And Functional Limitations

NCT05280977 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-03-15

No results posted yet for this study

Summary

Study Design: Randomized Controlled Trial treatment techniques: post isometric relaxation and post facilitation stretching technique sample size: 35 in each group single blinded Before giving either treatment to each group, baseline data will be collected from each participant and then after 4th week of treatment.

Conditions

  • Erector Spinae Tightness

Interventions

OTHER

POST ISOMETRIC RELAXATION

Group A (Post Isometric Relaxation + Conventional Physiotherapy): This group will receive Muscle Energy Technique in addition to conventional physiotherapy for the treatment of erector spinae tightness. The treatment will be given on alternate days for four weeks with 8 - 10 repetitions of METs per session.

OTHER

POST FACILITATION STRETCHING

Group B (Post Facilitation Stretching + Conventional Physiotherapy): This group will receive Post Facilitation Stretching Technique in addition to conventional physiotherapy for the treatment of erector spinae tightness. The treatment will be given on alternate days for four weeks with 8 - 10 repetitions of METs per session.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Principal Investigators

  • SYEDA RAHAT JABEEN, MSPT · University of Lahore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-03
Primary Completion
2022-04-02
Completion
2022-04-11

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05280977 on ClinicalTrials.gov